Boenning & Scattergood, Inc. Bristol Myers Squibb CO Transaction History

Boenning & Scattergood, Inc.

$622 Million
Q4 2022

A detailed history of Boenning & Scattergood, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Boenning & Scattergood, Inc. holds 47,463 shares of BMY stock, worth $2.24 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

47,463

Previous 48,233 1.6%

Holding current value

$2.24 Million

Previous $3.43 Million 1.08%

% of portfolio

0.56%

Previous 0.7%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	SELL	$68.48 - $81.09 $52,729 - $62,439	-770 Reduced 1.6%	47,463 $3.47 Million
Q3 2022 Oct 11, 2022	BUY	$0.13 - $76.84 $96 - $57,015	742 Added 1.56%	48,233 $3.43 Million
Q2 2022 Jul 13, 2022	BUY	$72.62 - $79.98 $2,033 - $2,239	28 Added 0.06%	47,491 $3.66 Million
Q1 2022 Apr 14, 2022	SELL	$61.48 - $73.72 $61,049 - $73,203	-993 Reduced 2.05%	47,463 $3.47 Million
Q4 2021 Jan 18, 2022	SELL	$53.63 - $62.52 $364,523 - $424,948	-6,797 Reduced 12.3%	48,456 $3.02 Million
Q3 2021 Oct 21, 2021	BUY	$59.17 - $69.31 $220,171 - $257,902	3,721 Added 7.22%	55,253 $3.27 Million
Q2 2021 Jul 21, 2021	SELL	$61.91 - $67.42 $298,963 - $325,571	-4,829 Reduced 8.57%	51,532 $3.44 Million
Q1 2021 Apr 22, 2021	SELL	$59.34 - $66.74 $304,888 - $342,910	-5,138 Reduced 8.35%	56,361 $3.56 Million
Q4 2020 Jan 20, 2021	BUY	$57.74 - $65.43 $193,429 - $219,190	3,350 Added 5.76%	61,499 $3.82 Million
Q3 2020 Oct 21, 2020	BUY	$57.43 - $63.64 $650,567 - $720,913	11,328 Added 24.19%	58,149 $3.51 Million
Q2 2020 Jul 14, 2020	BUY	$54.82 - $64.09 $33,714 - $39,415	615 Added 1.33%	46,821 $2.75 Million
Q1 2020 Apr 13, 2020	SELL	$46.4 - $67.43 $17,910 - $26,027	-386 Reduced 0.83%	46,206 $2.58 Million
Q4 2019 Jan 15, 2020	BUY	$49.21 - $64.19 $251,069 - $327,497	5,102 Added 12.3%	46,592 $2.99 Million
Q3 2019 Oct 15, 2019	SELL	$42.77 - $50.71 $211,069 - $250,253	-4,935 Reduced 10.63%	41,490 $2.1 Million
Q2 2019 Jul 15, 2019	SELL	$44.62 - $49.34 $23,693 - $26,199	-531 Reduced 1.13%	46,425 $2.11 Million
Q1 2019 Apr 22, 2019	BUY	$45.12 - $53.8 $90 - $107	2 Added 0.0%	46,956 $2.24 Million
Q4 2018 Jan 22, 2019	SELL	$48.76 - $63.23 $121,119 - $157,063	-2,484 Reduced 5.02%	46,954 $2.44 Million
Q3 2018 Oct 05, 2018	SELL	$55.19 - $62.25 $136,374 - $153,819	-2,471 Reduced 4.76%	49,438 $3.07 Million
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $2.62 Million - $3.27 Million	51,909 New	51,909 $2.87 Million

Others Institutions Holding BMY

# of Institutions

2,810

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $100B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boenning & Scattergood, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Boenning & Scattergood, Inc. with notifications on news.

Account

Boenning & Scattergood, Inc. Bristol Myers Squibb CO Transaction History